High- Versus Low-calcium Water for Bone Health

Sponsor
Istituto Ortopedico Galeazzi (Other)
Overall Status
Recruiting
CT.gov ID
NCT05772364
Collaborator
(none)
41
1
2
39
1.1

Study Details

Study Description

Brief Summary

The experimental study investigates which metabolic responses of calcium and parathyroid hormone are observable in blood and urine in a cohort of 41 healthy adults following a sequence of different exposures: low-calcium water first and high-calcium water afterward.

Condition or Disease Intervention/Treatment Phase
  • Other: Low-calcium water
  • Other: High-calcium water
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
41 participants
Allocation:
Non-Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Health Services Research
Official Title:
Metabolic Response to the Consumption of Waters With Different Calcium Content: a Cross-over Clinical Study
Actual Study Start Date :
Mar 2, 2023
Anticipated Primary Completion Date :
Mar 31, 2026
Anticipated Study Completion Date :
May 31, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Water loading phase 1

Participants drink 1.5 L of the designated water

Other: Low-calcium water
All cohort subjects are asked to consume the amount of water within two hours
Other Names:
  • Water with less than 5 mg/L of calcium
  • Experimental: Water loading phase 2

    Participants drink 1.5 L of the designated water

    Other: High-calcium water
    All cohort subjects are asked to consume the amount of water within two hours
    Other Names:
  • Water with at least 400 mg/L of calcium
  • Outcome Measures

    Primary Outcome Measures

    1. Change of blood calcium levels [Baseline and 2.5 hours]

      Change of calcium levels (mg/dL) from baseline and after 2.5 hours

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    25 Years to 55 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Body mass index ≥ 18 and < 30

    • Maintenance of diet and physical activity lifestyle throughout the duration of the study

    • Acceptance of informed consent

    Exclusion Criteria:
    • Consumption of water with calcium > 150 mg/L

    • Pregnancy (as established by self-declaration), breastfeeding, menopause

    • Inability to follow the study protocol

    • Cardiac, vascular, renal, and oncological disease

    • Neuropsychiatric disease, developmental disorders

    • Disease or past surgery affecting the gastrointestinal tract

    • Drugs that interfere with bone (e.g. corticosteroids) or with fluid balance (e.g. diuretics)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Istituto Ortopedico Galeazzi Milan Italy 20161

    Sponsors and Collaborators

    • Istituto Ortopedico Galeazzi

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Istituto Ortopedico Galeazzi
    ClinicalTrials.gov Identifier:
    NCT05772364
    Other Study ID Numbers:
    • CALIMOS
    First Posted:
    Mar 16, 2023
    Last Update Posted:
    Mar 16, 2023
    Last Verified:
    Mar 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 16, 2023